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Abstract
Background
Medication-related problems are common after hospitalization, for example when changes
in patients’ medication regimens are accompanied by insufficient patient education, poor
information transfer between healthcare providers, and inadequate follow-up post-dis-
charge. We investigated the effect of a pharmacy-led transitional care program on the occur-
rence of medication-related problems four weeks post-discharge.
Methods
A prospective multi-center before-after study was conducted in six departments in total of
two hospitals and 50 community pharmacies in the Netherlands. We tested a pharmacy-led
program incorporating (i) usual care (medication reconciliation at hospital admission and
discharge) combined with, (ii) teach-back at hospital discharge, (iii) improved transfer of
medication information to primary healthcare providers and (iv) post-discharge home visit
by the patient’s own community pharmacist, compared with usual care alone. The difference
in medication-related problems four weeks post-discharge, measured by means of a vali-
dated telephone-interview protocol, was the primary outcome. Multiple logistic regression
analysis was used, adjusting for potential confounders after multiple imputation to deal with
missing data.
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Results
We included 234 (January-April 2016) and 222 (July-November 2016) patients in the usual
care and intervention group, respectively. Complete data on the primary outcome was avail-
able for 400 patients. The proportion of patients with any medication-related problem was
65.9% (211/400) in the usual care group compared to 52.4% (189/400) in the intervention
group (p = 0.01). After multiple imputation, the proportion of patients with any medication-
related problem remained lower in the intervention group (unadjusted odds ratio 0.57; 95%
CI 0.38–0.86, adjusted odds ratio 0.50; 95% CI 0.31–0.79).
Conclusions
A pharmacy-led transitional care program reduced medication-related problems after dis-
charge. Implementation research is needed to determine how best to embed these interven-
tions in existing processes.
Introduction
The incidence of medication-related problems (MRPs) ranges from 18.4% two weeks post-dis-
charge to 37.5% four weeks post-discharge [1]. MRPs are defined as events or circumstances
related to a patient’s medication [2] that can adversely affect patients’ health status [3–5]. A
recent study showed that a median of 21% of hospital readmissions are due to MRPs, of which
a median of 69% are regarded as preventable [6]. Examples of MRPs are the continued use of
medication that had been discontinued in the hospital, side effects due to medication changes
in the hospital, interactions caused by the use of home medications which were unknown dur-
ing hospitalization (e.g. over-the-counter medication) or problems in implementing an altered
medication regimen at home [7].
There are several causes for these post-discharge MRPs [8]. They include the often numer-
ous changes made in medication regimens over a hospital stay [9, 10], which are not always
clear to patients [11, 12]. As a consequence, patients leave the hospital insufficiently educated
about the appropriate management of their altered medication regimen at home and experi-
ence difficulties in implementing this regimen [3, 5]. In addition, healthcare providers in pri-
mary care such as community pharmacists, general practitioners and home healthcare nurses
are often not informed regarding medication changes and reasons for these changes and,
therefore, have difficulties with monitoring a patients’ entire medication regimen [13–15].
Finally, there is no follow-up with the patient of medication-related problems that occur post-
discharge.
Several pharmacy-led transitional care programs have been designed to reduce MRPs and
improve the continuity of medication use by performing medication reconciliation (MR) [16–
19]. MR is the process of obtaining and maintaining a complete and accurate list of the
patients’ current medication use across healthcare settings [20], and has been shown to reduce
MRPs during transitions in care.
Although MR is a good strategy to reduce medication errors, the tool does not intercept
misunderstandings patients have about their medication, e.g. due to information overload, use
of medical terms or health illiteracy. A strategy to improve patient comprehension is the
“teach-back” method. This method allows healthcare providers to verify if patients and/or
their family members understand discharge instructions by letting them recapitulate the
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information they were provided [21]. This cycle of reassessing and teaching back has been
found to improve knowledge retention [22] and even lower readmission rates in heart failure
patients [23]. Other post-discharge MRPs, such as side effects, interactions and problems in
medication management can be addressed with post-discharge follow-up monitoring [7, 24–
32]. Furthermore, the most effective interventions seem to be those that focus on collaboration
between secondary and primary care incorporating a specific post-discharge strategy [1]. Until
now, research on reducing MRPs has primarily focused on performing MR, either at hospital
discharge or post-discharge without incorporating teach-back and connecting MR in second-
ary and primary care. Therefore, we designed a pharmacy-led transitional care program incor-
porating (i) MR at hospital admission and discharge (ii) teach-back at hospital discharge, (iii)
improved transfer of medication information to primary healthcare providers and (iv) a post-
discharge home visit by the patient’s own community pharmacist. This study aimed to primar-
ily investigate the effect of this pharmacy-led transitional care program on the occurrence of
MRPs four weeks post-discharge. Secondary outcomes were the number and type of interven-
tions conducted during the home visit, patient satisfaction and patient’s knowledge of medica-
tion changes implemented during hospitalization.
Methods
Study design and setting
A prospective multicenter before-after study was conducted in the Netherlands, Amsterdam. In
this study the departments of internal medicine, cardiology and pulmonology of a teaching hos-
pital (OLVG) and the departments of internal medicine, cardiology, and neurology of a general
hospital (BovenIJ), collaborated with 50 community pharmacies. These departments were
selected as they had already implemented MR. Usual care patients were included from January
through April 2016. In May and June the intervention was implemented and patients were
included in the intervention group from July through November 2016. The study was approved
by the local ethics committee “Adviescommissie Wetenschappelijk Onderzoek-Medisch-Ethische
Commissie” (ACWO-MEC) OLVG hospital (ID WO: 15.067) and the Board of Directors Bove-
nIJ hospital (ID WO: 5EMeh545). Written informed consent was obtained from all patients.
Study population
Pharmacy technicians, supervised by a pharmacist-researcher, assessed patient eligibility at least
24 hours before discharge. Participants had to have spent�24 hours in hospital, use a minimum
of three active chronic medications at discharge, defined as�3 prescriptions of a medicine in
the previous 6 months or prescriptions for�90 days in a year, and had to have at least one med-
ication change during hospitalization (excluding ‘as needed’ medication or medication pre-
scribed for less than 5 days after discharge). These criteria were chosen because previous studies
have shown that patients are prone to post-discharge MRPs if they use more than three medica-
tions and changes have been made in their medication regimen following hospitalization [3, 5].
Patients with more than one eligible admission within the duration of the study period, who
were discharged to another institution (e.g. rehabilitation center or nursing home) or who
could not be counseled due to physical/mental constraints, language restrictions, or those with
terminal illness (as judged by their hospital physician) were excluded from the study.
Usual care
MR was performed by (specialized) pharmacy technicians with background support of phar-
macists. Pharmacy technicians have shown to perform MR accurately in the Netherlands [33].
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In the Netherlands, pharmacy technicians have had a three year intermediate vocational train-
ing program that involves a combination of study in addition to practical working experience.
A pharmacy technician can specialize further into pharmaceutical consultants, who have
received an additional 3 year bachelor training focused on pharmacotherapy and communica-
tion [34].
For this study, the specialized pharmacy technicians were trained in executing medication
reconciliation and had checklists to support them with recognizing simple medication errors,
e.g. opioids without a laxative, or side effects, e.g. cough with ACE-inhibitors.
MR consisted of 4 steps (Fig 1) [20]. First, to gather information on actual medication use,
including over-the-counter medication, community pharmacy records were collected and dis-
cussed with the patient (verification). In the second step, pharmacotherapy was evaluated to
check whether optimization of medication was possible based on guidelines or side effects that
the patient experienced (clarification). In the third step, (reasons for) medication changes were
Fig 1. Overview of differences between usual care and intervention during hospitalization and post-discharge, and responsible party.
https://doi.org/10.1371/journal.pone.0213593.g001
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documented and patients were informed of these changes (reconciliation). Patients were
handed a personalized medication summary [34] containing information on medication
(brand and generic name of medication, dose/schedule, reason for change and start or stop
date), instructions about what to do in case side effects occur and clinical information (e.g.
allergies, contra-indications). The pharmacy technician discussed the findings of the three
steps with the hospital physician and if necessary adjustments were made in the medication
regimen. Finally, the complete medication overview, including information regarding aller-
gies, medication changes and relevant laboratory results were communicated to the commu-
nity pharmacy by fax within 24 hours after discharge. This information was also added to the
discharge summary to inform the general practitioner (transmission).
Intervention
The interventions were added to usual care (MR during hospitalization) and were performed
at discharge and post-discharge (Fig 1).
1) Teach-back at discharge. Teach-back communication was added to the third reconcili-
ation step of MR (Fig 1). Medication changes and specific care instructions (e.g. use of medica-
tion during fasting) were discussed with the patient (and/or their informal caregivers) and
highlighted on their personalized medication summary. Subsequently, they were asked to
‘teach-back’ their changes in medication, either verbally or by showing it on the medication
summary, to confirm patients’ understanding. Whenever these medication changes or relevant
instructions were not restated correctly, information was clarified or modified and checked
again, with a maximum of two reassessing and teaching back cycles. In case of unsuccessful
teach-back the community pharmacy was informed, who could incorporate additional checks
in patient understanding during the home visit.
2) Post-discharge communication with primary healthcare providers. Within 24 hours
after discharge the pharmacist-researcher informed the community pharmacist by telephone
on the primary reason of hospitalization and the level of support the patient received in using
medication at home prior to admission (e.g. assistance from a home healthcare nurse or infor-
mal caregiver) (Fig 1). The community pharmacist was also notified in case of unsuccessful
teach-back. Finally, the patients’ medication overview, highlighting the underlying reasons for
medication changes, was sent by email to the community pharmacist, home healthcare nurse
and general practitioner.
3) Post-discharge documentation of medication changes by community pharmacies.
In the Netherlands, more than 95% of patients collect medication at only one community
pharmacy [35] which registers all their medications in their individual electronic records. Pre-
vious studies have shown that even after communicating medication changes to primary
healthcare providers, this information is not always documented in a patient’s electronic
record [13, 36]. This inadequacy may hamper medication surveillance after hospital discharge
and the continuity of pharmaceutical care. Therefore, in this study community pharmacies
were instructed to also carefully document medication changes to ensure completeness of
their patients’ electronic records (Fig 1).
4) Home visit within five days post-discharge by community pharmacies. The main
goal of this home visit, conducted by the patient’s community pharmacist, was to perform MR
(Fig 1), discuss problems patients perceived with regard to their medication and focus on
MRPs relevant to the patient. During this visit, medication use (indication, dosage, time of
administration), knowledge of medication changes, (concerns about) side effects, doubts on
effectiveness of medication, practical problems (e.g. difficulty with administration of medica-
tion due to dysphagia), medication management (e.g. multi-dose drug dispensing system) and
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medication adherence were discussed. Patients were also asked to allow the pharmacist to take
any expired or discontinued medication for destruction. Finally, the pharmacist summarized
the main points of the discussion and, if possible, directly solved all MRPs that emerged.
If changes in medication were required, the pharmacist discussed these with the patient and
subsequently consulted the prescriber (either the general practitioner or hospital physician). If
applicable, home healthcare nurses, who were responsible for medication administration in
some patients, were informed about any medication changes. At the home visit all observa-
tions, recommendations and changes in pharmacotherapy were recorded by the pharmacist
on a home visit registration form and sent to the pharmacist-researcher.
Training. Following the usual care period, a communication skills training was given to
all pharmacy technicians about the teach-back method in the first two weeks of May, 2016.
Prior to the training a communication expert observed the communication techniques of the
pharmacy technicians during MR and used these observations to create the proper training.
During the training session all pharmacy technicians had to practice their teach-back tech-
nique with an actor. The progress of the teach-back technique was tracked by the pharmacist-
researcher who would occasionally visit a pharmacy technician during MR.
All participating community pharmacists received a one-day training from the ‘Dutch Insti-
tute for Rational Medicine Use (IVM)’ on how to appropriately conduct a home visit and deliver
it in a standardized fashion, while tailoring it to patients’ needs. Information and instructions
about conducting certain study elements were also given by the pharmacist-researcher, e.g. how
to properly and consistently record observations in the home visit registration form.
Data collection and outcomes
Patient characteristics (gender, age, length of stay) were extracted from the medical records of
the hospital information system. The primary outcome was the difference in proportion of
patients with any self-reported MRPs four weeks post-discharge, and the number of MRPs per
patient, in the intervention period compared to the usual care period.
The structured telephone interview, as presented in Questionnaire A in S1 Questionnaire,
was used to determine the occurrence of MRPs four weeks post-discharge and was conducted
by several pharmacist-researchers. This telephone interview is based on the face- and content
validated questionnaire developed by Willeboordse et al [37] and contains questions about
medication-related symptoms, effectiveness problems or concerns, user or practical problems
and remaining questions. Secondary outcomes were also assessed in the telephone interview
(Questionnaire B in S1 Questionnaire):
• Recall of all medication changes implemented during hospitalization [12].
• Patient satisfaction with medication use in general and counseling during MR at discharge.
• Patient satisfaction with the post-discharge home visit (for the intervention group only).
The interventions initiated by the community pharmacist at the home visit were extracted
by the pharmacist-researcher from the home visit registration form. They were classified into
three categories:
1. Discrepancies: correcting unintentional differences between the documented medication in
the discharge letter and actual medication use of the patient registered during the home
visit.
2. Optimization of medication: any optimization of pharmacotherapy that was conducted to
adhere to guidelines or reduce side effects, and
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3. Patient handling interventions: improving patients’ medication use (e.g. adherence issues,
problems with medication use due to dysphagia, explanation for patients’ questions).
Finally, the intervention fidelity of the study was determined to assess whether the interven-
tion was implemented as intended [38]. This was done by measuring the adherence of health-
care professionals to the study protocol, including the number of patients who had MR during
hospitalization (for both usual care and intervention group patients), teach-back at discharge
(which were registered by pharmacy technicians in existing resources in the hospital), number
of medication overviews transferred within 24 hours after discharge and number of home vis-
its within five days of discharge.
Statistical analysis
Based on results from a comparable study [26] it was estimated that a sample size of at least
200 patients per group was required to detect a decrease from 2.9 to 1.5 MRPs per patient,
with a withdrawal rate of 50% (2-sided alpha test of 0.05; power of 90%;SD 2).
The primary analysis compared the proportions of patients in the two groups who reported
at least one MRP four weeks post-discharge (using logistic regression analysis), and the treat-
ment effect on the number of MRPs per patient four weeks post-discharge (using negative
binomial regression analysis).
To enhance statistical stability, before conducting the latter analysis, we collapsed the sparse
categories of patients with five MRPs (two patients in the intervention group and three patients
in the usual care group) and six MRPs (two patients in the usual care group) into the category
with four MRPs. Before the analyses of the treatment effects on the primary outcomes, we cre-
ated 20 complete data sets using multiple imputation, separately for the usual care and inter-
vention group (Stata’s multiple imputation impute chained command (by group)).
Unadjusted and adjusted analyses were performed for the primary outcomes, the latter
adjusting for 14 confounders ((age (continuous; interquartile range (IQR)) 62–80), gender,
ethnicity (Dutch vs non-Dutch), education (primary only, secondary, more than secondary),
hospital (OLVG vs BovenIJ), type of admission (acute vs planned), length of hospital stay (con-
tinuous; IQR 4–9), number of medication at discharge (continuous; IQR 4–9), number of
medication changes following hospitalization (continuous; IQR 2–5), number of medication
in one of five Anatomical Therapeutic Chemical (ATC) classification groups (ordinal). The
five ATC groups, concerning medication for the alimentary tract and metabolism, blood and
blood forming organs, cardiovascular, nervous and respiratory system, were selected as they
were the most prescribed medication in this study population and are mostly associated with
the occurrence of MRPs [39, 40]. All other potential confounders were chosen as previously
conducted studies have shown that these variables are associated with our primary outcome
[3, 41, 42]. For example, several studies have shown that participants with a non-western back-
ground (non-native Dutch) more often have limited literacy skills compared to native Dutch
people which may be caused by difficulties in understanding information [43]. Limited literacy
skills are associated with poor understanding of medications and medication changes, and this
can lead to errors in medication use. Therefore, we adjusted for ethnicity in our analysis.
Furthermore, we explored if the treatment effect varied across four predetermined sub-
groups using treatment by subgroup interaction terms in the regression models: age (continu-
ous), ethnicity (Dutch vs non-Dutch), number of medications at discharge (continuous),
number of medication changes following hospitalization (continuous).
Treatment effects were expressed as odds ratios (OR) for logistic regression and incidence
rate ratios (IRR) for negative binomial regression, and their corresponding 95% confidence
intervals (CIs). Descriptive statistics were used to describe patient characteristics and
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secondary outcomes, and independent T tests and Chi-square tests were performed to analyze
differences (p<0.05 was considered significant). All data was stored in Microsoft Excel 2010
(Microsoft, Redmond, WA) and analyzed using IBM SPSS Statistics version 21.0.0.0 (IBM
Corp., Armonk, NY)) and Stata version 13.1 (Stata Corp., College Station, Texas).
Results
Study sample
In total, 3153 consecutive patients were assessed for eligibility from January through Novem-
ber 2016. 2697 (85.5%) patients were ineligible (Fig 2). Exclusions were mainly due to the
inability to counsel the patient (or informal caregiver), absence of changes in the medication
regimen and transfer to other institutions following hospital discharge.
In total, 456 patients were enrolled in the study (234 in the usual care group, 222 in the
intervention group). The baseline patient characteristics of both groups were essentially similar
(Table 1). However, as compared to intervention patients, usual care patients lived alone more
often (48.4% vs 37.4%, p = 0.02), had been hospitalized more often in the previous six months
before the index admission (36.8% vs 25.9%, p = 0.01) and experienced fewer changes in their
medication regimen following hospitalization (mean 3.6 vs 4.2, p = 0.01).
Fidelity of study protocol
Of the 234 patient included in the usual group and 222 patients in the intervention group, all
received MR at hospital admission and discharge (Fig 2). For all intervention group patients
the medication overview listing all medication changes and underlying reasons, was sent to
primary healthcare providers. In total 220 patients received teach-back at discharge (99.1%);
38 patients (17.3%) could not successfully teach-back. In total, 197 patients (88.7%) were vis-
ited at home by their pharmacist. The remaining participants (n = 25) could not be visited due
to various reasons that are specified in Fig 2. For 211 (90.2%) usual care patients and 189
(85.1%) intervention patients we had complete data on their primary outcome.
Home visit five days post-discharge
The pharmacist spent a median of 40 minutes (IQR: 30–50 minutes) on the home visit, exclud-
ing the travel time and performed interventions after the home visit for 192 (97.5%) patients
(Table 2). Pharmacists identified discrepancies for 92 patients (46.7%) in the verification step
of MR (Fig 1). These discrepancies were mostly omission errors (38.1%), as patients often used
medications that were not identified in the hospital (e.g. over-the-counter products). In the
clarification step, pharmacists had to make changes in the medication for 43 (21.8%) patients.
Mainly, dosages of medication were adjusted (e.g. increasing dose of painkillers for adequate
pain-relief, reducing doses due to side effects). Finally, during the reconciliation step, for nearly
all patients (96.4%) patient-handling interventions were conducted due to a necessity for addi-
tional education on medication (65.0%), disposal of discontinued medication (50.3%) and
answering questions concerning medication (35.5%).
Primary outcome four weeks post-discharge
The proportion of patients with at least one MRP four weeks post-discharge was lower in the
intervention group than in the usual care group (52.4% vs 65.9%; p = 0.01) (Table 3). This was
mainly because of fewer symptoms caused by medication, such as gastrointestinal disorders or
severe muscle pain (24.6% vs 16.4%; p = 0.04; unadjusted OR 0.60; 95% CI 0.37–0.99), and less
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concerns on the safety of medication use, such as fear of potential side effects (25.1% vs. 16.4%;
p = 0.03; unadjusted OR 0.58; 95% CI 0.36–0.96).
After multiple imputation, the proportion of patients with at least one MRP remained
lower in the intervention group (unadjusted OR 0.57; 95% CI 0.38–0.86, adjusted OR 0.50;
95% CI 0.31–0.79). Likewise, the number of MRPs per patient was lower for patients in the
intervention group than in the usual care group (mean 0.91 vs 1.32; p<0.01), also after multi-
ple imputation (unadjusted IRR 0.70; 95% CI 0. 58–0.85, adjusted IRR 0.69; 95% CI 0.55–
0.86). Finally, the subgroup analyses provided no evidence that the effect of the intervention
Fig 2. Flowchart of participants.
https://doi.org/10.1371/journal.pone.0213593.g002
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varied among the four predefined subgroups of patients (age, ethnicity, number of medication
at discharge and number of medication changes following hospitalization).
Secondary outcome measures four weeks post-discharge
The recall rate regarding all in-hospital medication changes was higher for patients receiving
the intervention compared to usual care (42.0% vs 30.2%, p = 0.01). Patients were mostly
Table 1. Baseline patient characteristics.
Usual care (n = 234) Intervention (n = 222) P-value
Hospital of admission, n (%) 0.14
• BovenIJ 76 (32.5) 87 (39.2)
• OLVG, location West 158 (67.5) 135 (60.8)
Admission type, n (%) 0.86
• Unplanned 213 (91.0) 201 (90.5)
• Planned 21 (9.0) 21 (9.5)
Ward type, n (%) 0.57
• Cardiology 116 (49.6) 108 (48.6)
• Internal Medicine 67 (28.6) 59 (26.6)
• Pulmonology 45 (19.2) 43 (19.4)
• Neurology 6 (2.6) 12 (5.4)
Length of hospital stay, days, median (Interquartile range (IQR)) 6.0 (4.0–9.0) 6.0 (4.0–9.0) 0.92
Hospitalization� 6 months before index admission, ne (%) 85 (36.8) 57 (25.9) 0.01
Gender, male, n (%) 130 (55.6) 124 (55.9) 0.95
Ethnicity, n (%) 0.54
• Dutch 169 (72.2) 166 (74.8)
• Non-Dutch 65 (27.8) 56 (25.2)
Age, year, mean ± SD 70.8 ± 11.9 70.2 ± 12.8 0.58
Living situation, na (%) 0.02
• Alone 107 (48.4) 83 (37.4)
• Together 114 (51.6) 139 (62.6)
Educationb, nc (%) 0.57
• Primary education 94 (41.0) 97 (44.7)
• Secondary education 97 (42.4) 82 (37.8)
• Higher education 38 (16.6) 38 (17.5)
Number of medications at discharge, mean ± SD 10.1 ± 3.9 10.2 ± 4.1 0.85
Number of medication changes following hospitalization, mean, per patient, ± SD 3.6 ± 2.1 4.1 ± 2.2 0.01
Typed of medication change, n (%)
• New 191 (81.6) 200 (90.1) 0.01
• Stop 82 (35.0) 86 (38.7) 0.41
• Dose change 98 (41.9) 74 (33.3) 0.06
• Switch 44 (18.8) 47 (21.2) 0.53
a 13 missing values in usual care group.
b Primary education: elementary or primary school. Secondary education: pre-vocational, senior general or pre-university. Higher education: higher professional or
university.
c 5 missing values in both usual care and intervention group.
d Some patients had more than one type of medication change.
e 3 missing values in usual care group and 1 in intervention group; information could not be provided or was missing.
https://doi.org/10.1371/journal.pone.0213593.t001
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unable to recall an in-hospital discontinuation of chronic medication they used before hospital
admission. Furthermore, more patients in the intervention group were satisfied with their
medication use in general (82.0% vs 67.6%, p<0.01) and with MR at discharge (87.7% vs
71.1%, p<0.01) as compared to patients in the usual care group.
In total, 87.5% of patients thought the home visit was useful and that the pharmacist pro-
vided satisfactory answers to questions about their medication. Furthermore, 60.7% of patients
were willing to have a second home visit by their pharmacist in case of another discharge from
the hospital. Some patients (10.4%) were not sure whether a home visit was necessary and said
it would depend on the number or type of changes conducted in the medication regimen dur-
ing hospitalization.
Table 2. MR interventions conducted by community pharmacist at the post-discharge home visit (n = 197).
Type of intervention na (% of
patients)
(1) Discrepancies (start, dosage/schemes, stop, switch)b,c 92 (46.7)
Start 74 (38.1)
Dosage regimen 24 (12.2)
Stop 4 (3.0)
Switch 1 (0.5)
(2) Optimizations (start, dosage/schemes, stop, switch)d 43 (21.8)
Dosage regimen 18 (9.1)
Stop 17 (8.6)
Start 12 (6.1)
Switch 4 (2.0)
(3) Patient handling interventions 190 (96.4)
Education about medication indication 128 (65.0)
Disposal of expired/unused medications 99 (50.3)
Answering questions concerning medication (e.g. difference between brand name and generic
prescriptions, how to order new medication)
70 (35.5)
Medication compliance advice 61 (31.0)
Advice on how to reduce Medication-related problems (MRPs) 52 (26.4)
Advice on time of administration and intended duration of treatment 50 (25.4)
Advice for practical problems with medicines use (e.g. dosing aids, solutions for swallowing
problems)
22 (11.2)
Advice on administration of medication (e.g. inhalation, injection) 17 (8.6)
Logistics (e.g. registering medication allergies in pharmacy information system) 15 (7.6)
a Number of patients for whom at least one intervention was conducted. More than one intervention could have been
conducted per patient. For example, for the subsection patient handling interventions: advice about how to increase
adherence and also on administration times.
b Information obtained during the home visit was considered to be the most complete and accurate.
c Discrepancies were either classified as (1) Start: omission; incorrect deletion of a medication, (2) Dosage regimen:
schedule of doses of a medicine, including the time between doses, the duration of treatment, the amount to be taken
each time, how a medicine is to be taken, and in what dosage form. (3) Stop: commission; incorrect addition of a
medication, or (4) Switch: incorrect medication.
d Optimizations were either classified as (1) Dosage and scheme: dosage, administering time, medication regimen, or
duration of therapy inappropriate or prescription incomplete or unclear, (2) Stop: indication no longer present, (3)
Start: under treatment; medication added based on protocols and best practice standards, or (4) Switch: medication
prescribed not appropriately (e.g. contraindication).
https://doi.org/10.1371/journal.pone.0213593.t002
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Discussion
The present pharmacy-led transitional care program was designed to reduce MRPs post-dis-
charge. The results show that the proportion of patients with at least one MRP four weeks
post-discharge was indeed 13.5% lower in the group who received a combination of hospital
discharge interventions with a home follow-up visit of the community pharmacist as com-
pared to the group who received usual care. Intervention group patients also reported less
symptoms caused by their medication. These symptoms could be potential adverse drug events
(ADEs) which are known to increase healthcare use [5, 44] and costs [45].
The reduction of MRPs was seen despite the high standard of usual care patients already
receive during hospitalization (including MR at hospital admission and discharge), and under-
lines the need of additional post-discharge care. The findings show that after discharge nearly
two thirds of patients in the intervention group required additional education about medica-
tion (use), such as the indication or intended duration of a treatment. This finding is consis-
tent with previous studies [26, 46, 47]. By performing MR in the hospital, primary care
providers such as community pharmacists could focus on other MRPs, such as side-effects,
education on medication and a check on whether patients adhered to the medication pre-
scribed at discharge [3, 5, 31, 48, 49]. Nevertheless, four weeks post-discharge the proportion
of patients with at least one MRP remained high in the intervention group (52.4%). This rate is
higher than the studies included in the review by Garcia-Caballos et al [1], in which they show
the incidence of MRPs range from 18.4% two weeks post-discharge to 37.5% four weeks post-
discharge. However, in the current study, we assessed the prevalence of MRPs four weeks post-
discharge. Furthermore, some MRPs need more time to be resolved and not all reported MRP
can be prevented or resolved. For example, patients disliked diuretics due to their mechanism
of action (frequent voiding), but had an indication for diuretics (e.g. management of heart fail-
ure). However, as MRPs were self-reported by patients, overestimation of actual MRPs is pos-
sible. Still, the same MRP classification system was used for both usual care and intervention
patients, and therefore we expect any aberrations of MRPs to be similar for both treatment
groups. Previous studies have also identified patients’ valuable role in reporting problems due
to medication [50] and have shown their ability to identify these problems [51].
The intervention, including teach-back, also improved recall rates of in-hospital medication
changes. Nevertheless, still over half of intervention patients was not able to recall all medica-
tion changes post-discharge, which was also reported in other studies [11, 12]. A possible
explanation may be that the recall was determined long after discharge. Moreover, the
Table 3. Patient-reported medication-related problems (MRPs) four weeks post-discharge.
Usual care
(n = 211)
Intervention (n = 189) OR (95% CI) P-value
Total MRPs, n (%) 139 (65.9) 99 (52.4) 0.57 (0.38–0.86; adjusted: 0.50 (0.31–0.79)a 0.01
Number of MRPs per patient, mean ± SD 1.3 ± 1.4 0.9 ± 1.1 IRR 0.70 (0.58–0.85); adjusted; 0.69 (0.55–0.86)a 0.00
Type of MRP OR (95% CI) P-value
Medication-related symptoms, n (%) 52 (24.6) 31 (16.4) 0.60 (0.37–0.99) 0.04
Doubts, n (%) 33 (15.6) 25 (13.2) 0.82 (0.47–1.44) 0.50
Concerns, n (%) 53 (25.1) 31 (16.4) 0.58 (0.36–0.96) 0.03
Practical problems, n (%) 44 (20.9) 35 (18.5) 0.86 (0.53–1.41) 0.56
Difficulties, n (%) 31 (14.7) 18 (9.5) 0.61 (0.33–1.13) 0.12
Questions, n (%) 47 (22.3) 26 (13.8) 0.56 (0.33–0.94) 0.03
a After multiple imputation analysis (n = 456).
https://doi.org/10.1371/journal.pone.0213593.t003
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assessment took place during a telephone interview and patients were not always able to recall
all changes as not all patients had their medication (overview) with them during the interview.
Overall, this pharmacy-led transitional care program is promising with high adherence to
the intervention protocol (fidelity); nearly 90% of patients received the complete intervention
from hospital to home. However, the economic feasibility of the intervention should also be
taken into account. Not all patients are in need of this intensified type of (follow-up) care. Cur-
rently community pharmacist are not compensated for home visits that focus on medication
reconciliation. However, pharmacist are compensated for home visits that incorporate medi-
cation reviews. Future research is needed to determine if pharmacy-led interventions can be
embedded in existing processes in collaboration with other healthcare providers who already
visit patients at home, such as home healthcare nurses who can assist in early recognition of
potential MRPs.
The strengths of this study were the high fidelity to the intervention protocol, the participa-
tion of two hospitals and 50 community pharmacists, and the multiple imputation analysis to
repair any impact of potentially selective drop-out on the primary outcome.
Our study had several limitations. First, patients were not randomized as contamination
bias was possible at the hospital and community pharmacy level. This could dilute the real
effects as the intervention intended for members of the intervention arm of a study could also
be received by members of the usual care arm [26]. Second, the number of exclusions was high
(86%) in both groups which might affect the generalizability of the study results. However,
55% of patients were deliberately not invited for participation because they did not fulfil inclu-
sion criteria. Third, a before—after study design was used and therefore assessors who inter-
viewed patients to determine MRPs could not be blinded to the exposure status of the
participants. Several strategies were implemented to reduce observer bias, including the use of
a standardized interview protocol, assessment by several pharmacist-researchers and a training
for all assessors in how to interview patients and adequately document findings. Finally, we
did not assess the effect of the intervention on clinical outcomes such as readmissions as our
sample size would not be large enough to ensure adequate power. Therefore, more research is
needed to study the effect of transitional care collaborations on clinical outcomes. Some prom-
ising results have already been shown in a recently published randomized trial in which a mul-
tifaceted pharmacist led intervention reduced the number of patients’ emergency department
visits and hospital readmissions [52].
Conclusion
Application of a pharmacy-led transitional care program resulted in a reduction in the propor-
tion of patients with any self-reported MRPs, and the number of MRPs per patient, four weeks
post-discharge. Follow-up care after hospitalization and close collaboration among healthcare
providers across health care institutions is needed to identify, resolve and prevent MRPs and
to improve the continuity of medication use. Implementation research is needed to determine
how best to embed these interventions in existing processes and to determine the effect on
clinical outcomes.
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